Benda Pharmaceutical: Plans to issue H shares and list on the main board of the Hong Kong Stock Exchange

智通財經
2025.09.10 12:25
貝達藥業公告稱，為提升資本實力和綜合競爭力，深入推進國際化進程，公司擬發行境外上市股份並申請在香港聯交所主板掛牌上市。公司將充分考慮現有股東利益和境內外資本市場情況，在股東大會決議有效期內選擇適當時機和發行窗口完成本次發行上市。目前，公司正與相關中介機構就本次發行上市的相關工作進行商討，具體細節尚未最終確定。本次發行上市尚需提交公司股東大會審議，並需取得中國證監會和香港聯交所等相關政府機關、監管機構、證券交易所備案、批准和/或核准。
Source: 智通財經 The copyright of this article belongs to the original author/organization.
The views expressed herein are solely those of the author and do not reflect the stance of the platform. The content is intended for investment reference purposes only and shall not be considered as investment advice. Please contact us if you have any questions or suggestions regarding the content services provided by the platform.